Thermo Fisher Scientific’s therapeutics supply team enables our partners to develop and commercialize therapeutic solutions through strategic relationships. Integrating our platform technologies, products, capabilities, and intellectual property, together we can accelerate the delivery of next-generation therapeutics to market.
To learn more about our partnering opportunities or to speak with a therapeutic portfolio specialist, please submit an inquiry below.
DNA and RNA therapeutics
Thermo Fisher Scientific enables your entire DNA and RNA therapeutic development, manufacturing workflow from molecule synthesis, purification, and formulation and delivery.
For mRNA-based therapeutic development see our product offering, from in vitro transcription through in vivo delivery
Nucleic acid synthesis
- Enzymes (e.g. 2’-O-Methyltransferase, T7 RNA polymerase, poly A polymerase, etc.)
- Phosphoramidites (DNA and RNA)
- Cap analog (ARCA)
Formulation and delivery
Cell and gene therapy
We’re uniquely positioned to address the specific needs of the cell therapy market through integrated solutions that help your process development reach high quality manufacturing.
Application-driven media development service
- Serum replacement
Cell isolation, activation, and expansion
- Dynabeads CD3/CD28
- Application-drive custom Dynabeads development service
Ex vivo and in vivo gene delivery
We possess a breadth of host cells, cell engineering, and protein expression tools and technologies to assist your protein therapeutic development and commercialization.
In the news
For Research Use Only. Not for use in diagnostic procedures.